We are live on
!
Find out more
FGI
Foresight Global Investors Portfolio holdings
AUM
$154M
1-Year Est. Return
26.15%
This Fund
S&P 500
This Quarter
Est. Return
+8.02%
1 Year Est. Return
+26.15%
3 Year Est. Return
+62.89%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$203M
AUM Growth
+$28.7M
(+16%)
Cap. Flow
+$19.5M
Cap. Flow
% of AUM
9.61%
Top 10 Holdings %
Top 10 Hldgs %
77.86%
Holding
47
New
8
Increased
15
Reduced
6
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVO
Novo Nordisk
NVO
|
+$17.7M |
| 2 |
Novartis
NVS
|
+$6.71M |
| 3 |
Sony
SONY
|
+$4.43M |
| 4 |
Teck Resources
TECK
|
+$3.71M |
| 5 |
Mitsubishi UFJ Financial
MUFG
|
+$3.52M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$17.4M |
| 2 |
Diageo
DEO
|
+$3.59M |
| 3 |
Tenaris
TS
|
+$2.2M |
| 4 |
L3Harris
LHX
|
+$1.41M |
| 5 |
Abbott
ABT
|
+$1.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.13% |
| 2 | Healthcare | 22.15% |
| 3 | Energy | 21.88% |
| 4 | Financials | 18.63% |
| 5 | Industrials | 6.41% |
Similar funds
FW
SHU
AFC
SOWAS
CPCP
CCA
PWA
PWC
Foresight Global Investors's Q1 2024 Portfolio in Review
As of Q1 2024, Foresight Global Investors held 47 positions worth $203M, up 16% from $174M the previous quarter. Its ten largest holdings account for 78% of the portfolio.
Foresight Global Investors deployed $19.5M of net new capital in Q1 2024, opening 8 new positions and adding to 15 existing holdings. Its largest new stake was Novo Nordisk: 148,850 shares worth $19.1M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Healthcare and Energy.
On the sell side, the largest reduction was Tenaris, an estimated $2.2M trimmed.
- Foresight Global Investors's largest Q1 2024 buy was Novo Nordisk: 148,850 shares worth $19.1M.
- Foresight Global Investors added most to Novartis in Q1 2024, an estimated $6.71M increase.
- Foresight Global Investors's biggest Q1 2024 reduction was Tenaris, cutting an estimated $2.2M.
- Foresight Global Investors fully exited AstraZeneca in Q1 2024, selling an estimated $17.4M.
- Foresight Global Investors's ten largest holdings make up 78% of its $203M portfolio in Q1 2024.
- Foresight Global Investors opened 8 new positions and closed 8 in Q1 2024.
- Foresight Global Investors's portfolio value rose 16% quarter-over-quarter to $203M.
Based on Foresight Global Investors's 13F filing for Q1 2024, filed 10 May 2024.